Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,722.00
Bid: 1,721.00
Ask: 1,723.00
Change: 3.00 (0.17%)
Spread: 2.00 (0.116%)
Open: 1,722.00
High: 1,726.00
Low: 1,716.00
Prev. Close: 1,719.00
SMIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Euro Medium Term Note Programme

20 Oct 2017 14:17

RNS Number : 2311U
Smiths Group PLC
20 October 2017
 

 

News Release

London, 20 October 2017

For immediate release

 

 

€2.5bn Euro Medium Term Note Programme

Smiths Group plc (the "Company") announces today that it has updated its €2.5 billion Euro Medium Term Note Programme (the "EMTN programme") with its 10 relationship banks as dealers.

The EMTN programme will continue to facilitate the issuance by the Company of senior notes over time in various currencies and maturities. Notes issued under the EMTN programme will be guaranteed by Smiths Group International Holdings Limited.

Bill Seeger, Chief Financial Officer, said:

"This programme continues to be an essential foundation for our financing strategy having been the vehicle for the €650m 2% 10 year notes issued in February 2017. We aim to finance our balance sheet from the rated public debt markets and the programme provides us with considerable flexibility in both the refinancing of existing debt maturities and to support the strategic development of our business portfolio."

A base prospectus dated 20 October 2017 relating to the update of the EMTN programme (the "Prospectus") has been approved by the UK Listing Authority and is available for viewing.

To view the Prospectus, please paste the following URL into the address bar of your browser: http://www.rns-pdf.londonstockexchange.com/rns/2311U_1-2017-10-20.pdf

The Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.Hemscott.com/nsm.do. 

ENDS

 

 

Contact details

 

Investor enquiries

Jemma Spalton, Smiths Group

+44 (0)20 7004 1637

+44 (0)78 6739 0350

jemma.spalton@smiths.com

 

Marion Le Bot, Smiths Group

+44 (0)20 7004 1672

+44 (0)75 8315 4386

marion.lebot@smiths.com

 

Media enquiries

Andrew Lorenz, FTI Consulting

+44 (0)203 727 1323

+44 (0)777 564 1807

smiths@fticonsulting.com

 

Deborah Scott, FTI Consulting

+44 (0)203 727 1459

+44 (0)797 953 7449

smiths@fticonsulting.com

 

Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Our products and services make the world safer, healthier and more productive. Smiths Group employs 22,000 people in over 50 countries. For more information visit www.smiths.com

 

 

Disclaimer - intended addressees

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained therein.

In particular, the Prospectus does not constitute an offer of securities for sale in the United States. Neither the Prospectus nor this announcement is intended for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States.

Your right to access this service is conditional upon complying with the above requirement.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGMMZGFGZGNZM
Date   Source Headline
31st Jan 20185:02 pmRNSTotal Voting Rights
22nd Jan 20187:00 amRNSDivestment of John Crane's Bearings business
12th Jan 20187:00 amRNSSmiths statement on impact of US tax legislation
3rd Jan 20189:30 amRNSDirectorate Change
2nd Jan 20183:00 pmRNSDirector Declaration
2nd Jan 201810:15 amRNSTotal Voting Rights
6th Dec 20177:00 amRNSSmiths Group Capital Markets Day
30th Nov 20175:15 pmRNSTotal Voting Rights
14th Nov 20173:00 pmRNSResult of AGM
14th Nov 20177:00 amRNSTrading Statement
1st Nov 20171:45 pmRNSBlock listing Interim Review
1st Nov 20171:45 pmRNSTotal Voting Rights
1st Nov 201710:45 amRNSDirector/PDMR Shareholding
30th Oct 201711:00 amRNSHolding(s) in Company
27th Oct 20173:00 pmRNSDirector/PDMR Shareholding
20th Oct 20172:17 pmRNSEuro Medium Term Note Programme
20th Oct 20177:00 amRNSSmiths Group extends pension de-risking
17th Oct 20177:00 amRNSDirectorate Change
10th Oct 20172:30 pmRNSAnnual Financial Report
6th Oct 20179:30 amRNSHolding(s) in Company
2nd Oct 201712:15 pmRNSTotal Voting Rights
22nd Sep 20177:00 amRNSFinal Results
31st Aug 20175:15 pmRNSTotal Voting Rights
30th Aug 201711:45 amRNSAnnouncement of Results & Annual General Meeting
29th Aug 201711:35 amRNSHolding(s) in Company
1st Aug 201710:30 amRNSDirector/PDMR Shareholding
31st Jul 20175:15 pmRNSTotal Voting Rights
20th Jul 20177:00 amRNSNotification of Proposed Transactions by PDMR
10th Jul 20171:30 pmRNSDisposal Update
3rd Jul 201710:06 amRNSDirector/PDMR Shareholding
30th Jun 20175:23 pmRNSTotal Voting Rights
9th Jun 20174:11 pmRNSHolding(s) in Company
8th Jun 201710:19 amRNSAdditional Listing
1st Jun 20172:00 pmRNSDisposal
31st May 20175:46 pmRNSTotal Voting Rights
19th May 201710:57 amRNSDirectorate Change
3rd May 20177:00 amRNSDirector/PDMR Shareholding
2nd May 20179:21 amRNSBlock listing Interim Review
2nd May 20179:14 amRNSTotal Voting Rights
2nd May 20177:00 amRNSSmiths Group divests Microwave Telecoms business
7th Apr 20177:00 amRNSSmiths completes acquisition of Morpho Detection
5th Apr 201712:01 pmRNSDirector/PDMR Shareholding
31st Mar 20175:01 pmRNSTotal Voting Rights
24th Mar 20177:00 amRNSHalf-year Report
28th Feb 20175:02 pmRNSTotal Voting Rights
24th Feb 20177:01 amRNSDirector Declaration
21st Feb 20175:01 pmRNSPublication of Final Terms
16th Feb 20173:10 pmRNSSMITHS LAUNCHES 10 YEAR EUR650m BOND OFFERING
1st Feb 20177:00 amRNSSmiths Group extends pension de-risking
31st Jan 20176:15 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.